Shamburg News · 8-K filed Oct 19, 2026, 8:49 AM EDT
IRulya Therapeutics Posts Updated October 2026 Corporate Presentation on Website
IRLA · IRulya Therapeutics Inc.
- Reg FD disclosure
- Other event
- Materiality: low
On October 19, 2026, IRulya Therapeutics Inc. posted its Corporate Presentation, dated October 2026, on its investor website. The presentation is furnished as Exhibit 99.1 under Item 7.01 (Regulation FD Disclosure) and is not deemed filed under Section 18 of the Exchange Act. The presentation describes the company's LAM-001 inhaled rapamycin programs in PH-ILD, BOS and SAPH and their anticipated data readouts.
Source: SEC EDGAR, Form 8-K, Items 7.01, 9.01, accession 0001193125-26-424731.
Written from the filing by Shamburg Markets. Figures are as reported by the company.